Cargando…
Increased hepatic and circulating chemokine and osteopontin expression occurs early in human NAFLD development
BACKGROUND & AIMS: Non-alcoholic steatohepatitis (NASH), a subtype of non-alcoholic fatty liver disease (NAFLD) that can lead to fibrosis, cirrhosis, and hepatocellular carcinoma, is characterized by hepatic inflammation. Despite evolving therapies aimed to ameliorate inflammation in NASH, the t...
Autores principales: | Kriss, Michael, Golden-Mason, Lucy, Kaplan, Jeffrey, Mirshahi, Faridoddin, Setiawan, V. Wendy, Sanyal, Arun J., Rosen, Hugo R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392333/ https://www.ncbi.nlm.nih.gov/pubmed/32730345 http://dx.doi.org/10.1371/journal.pone.0236353 |
Ejemplares similares
-
Restoration of CD4(+) T Cells during NAFLD without Modulation of the Hepatic Immunological Pattern Is Not Sufficient to Prevent HCC
por: Isbell, Madison, et al.
Publicado: (2022) -
Dysregulated Hepatic Methionine Metabolism Drives Homocysteine Elevation in Diet-Induced Nonalcoholic Fatty Liver Disease
por: Pacana, Tommy, et al.
Publicado: (2015) -
Development of Alcohol‐Associated Hepatitis Is Associated With Specific Changes in Gut‐Modified Bile Acids
por: Muthiah, Mark D., et al.
Publicado: (2022) -
An Update on the Chemokine System in the Development of NAFLD
por: Nagata, Naoto, et al.
Publicado: (2022) -
Second-Harmonic Generated Quantifiable Fibrosis Parameters Provide Signatures for Disease Progression and Regression in Nonalcoholic Fatty Liver Disease
por: Ng, Nicole, et al.
Publicado: (2023)